|
Originally published In Press as doi:10.1074/jbc.M208471200 on September 27, 2002
J. Biol. Chem., Vol. 277, Issue 50, 48002-48008, December 13, 2002
Protein Phosphatase-1 Binding to Scd5p Is Important for
Regulation of Actin Organization and Endocytosis in Yeast*
Ji Suk
Chang ,
Kenneth
Henry §,
Bianka L.
Wolf¶,
Maribel
Geli¶, and
Sandra K.
Lemmon
From the Department of Molecular Biology and
Microbiology, Case Western Reserve University,
Cleveland, Ohio 44106-4960 and ¶ Biochemie-Zentrum, University
of Heidelberg, Im Neuenheimer Feld 328, 69120 Heidelberg, Germany
Received for publication, August 19, 2002, and in revised form, September 25, 2002
 |
ABSTRACT |
SCD5, an essential gene, encodes a
protein important for endocytosis and actin organization in yeast.
Previous two-hybrid screens showed that Scd5p interacts with Glc7p, a
yeast Ser/Thr-specific protein phosphatase-1 (PP1) that participates in
a variety of cellular processes. PP1 substrate specificity in
vivo is regulated by association with different regulatory or
targeting subunits, many of which have a consensus PP1-binding site
((V/I)XF, with a basic residue at the 1 or 2 position).
Scd5p contains two of these potential PP1-binding motifs: KVDF (amino
acids 240-243) and KKVRF (amino acids 272-276). Deletion analysis
mapped the PP1-binding domain to a region of Scd5p containing these
motifs. Therefore, the consequence of mutating these two potential
PP1-binding sites was examined. Although mutation of KVDF had no
effect, alteration of KKVRF dramatically reduced Scd5p interaction with
Glc7p and resulted in temperature-sensitive growth. Furthermore, this
mutation caused defects in fluid phase and receptor-mediated
endocytosis and actin organization. Overexpression of GLC7
suppressed the temperature-sensitive growth of the KKVRF mutant and
partially rescued the actin organization phenotype. These results
provide evidence that Scd5p is a PP1 targeting subunit for regulation of actin organization and endocytosis or that Scd5p is a PP1 substrate, which regulates the function of Scd5p in these processes.
 |
INTRODUCTION |
Protein phosphatase-1
(PP1)1 is one of the major
Ser/Thr protein phosphatases of eukaryotic cells (1). It is highly
conserved and is involved in a wide variety of cellular processes,
including glycogen and protein synthesis, cell cycle regulation, muscle contraction, and calcium transport (1, 2). Whereas the catalytic enzyme
has broad substrate specificities in vitro, many lines of
evidence have shown that regulatory or targeting subunits direct PP1 to
physiological substrates or subcellular locations to perform specific
dephosphorylation in vivo (2, 3).
In Saccharomyces cerevisiae the PP1 catalytic subunit is
encoded by GLC7, and not surprisingly because of its diverse
functions, GLC7 is an essential gene (4, 5). Many
Glc7p-regulatory proteins have been identified in yeast. These include
the following: Gac1p, a homologue of the mammalian G subunit involved
in activation of glycogen synthase for glycogen accumulation (6, 7);
Reg1p, which binds PP1 to regulate glucose repression (8, 9); Red1p and
Gip1p, which play roles in meiosis and sporulation (10-12); Egp1p/Sds22p, which targets PP1 to substrates whose dephosphorylation is required for completion of mitosis (13-15); and Glc8p, a homologue of the mammalian PP1 inhibitor-2 (16, 17).
Several mammalian and yeast PP1-binding proteins contain a consensus
PP1-binding motif ((V/I)XF) with a basic residue at the 1
or 2 position ((R/K)(V/I)XF or
(R/K)X(V/I)XF) through which the regulatory
subunits interact with the PP1 catalytic subunit (18, 19). This
structural motif forms an extended conformation and binds to a
hydrophobic groove (a regulatory subunit-binding site) on the PP1
protein surface, which is on the opposite side from the catalytic site
(18). The presence of a consensus PP1-binding motif also implies that
the interaction of many different regulatory subunits with PP1 is
mutually exclusive and competitive. However, the (V/I)XF
motif exists in more than 10% of all known proteins. Most of these are
unlikely to interact with PP1, so the importance of this motif for PP1
binding and function has required confirmation by mutational analysis
of the (V/I)XF sequence, as done for yeast Gac1p (20) and
Reg1p (21) and mammalian PTG (22), NIPP1 (23), and Nrb I (24).
A number of protein interaction screens have identified additional
PP1-binding proteins in yeast (10, 25, 26). Among these is Scd5p, an
872-amino acid protein, which we have shown recently (27) plays a
critical role in actin cytoskeleton organization and endocytosis.
Interestingly, Scd5p contains two potential PP1-binding motifs: KVDF
and KKVRF (amino acids 240-243 and 272-276, respectively). In this
report we map the Glc7p/PP1-binding site to a region of Scd5p
containing these motifs. Mutational analysis indicates that the second
putative PP1-binding site (KKVRF) is crucial for Glc7p interaction.
Furthermore, this PP1-binding site mutation causes temperature-sensitive growth and defects in actin cytoskeleton organization and endocytosis. These studies indicate that PP1 binding
is necessary for the function of Scd5p and suggest that Scd5p may
target PP1 to substrates that must be dephosphorylated for regulation
of actin organization and endocytosis.
 |
EXPERIMENTAL PROCEDURES |
Strains, Media, and Growth Conditions--
Strains
used in this study are listed in Table I.
Yeast were grown in 1% yeast extract, 2% peptone with 2% glucose
(YEPD) or other sugars as indicated or selective dropout medium as
described previously (28). Synthetic medium containing 5-fluoroorotic acid (5-FOA) was prepared as described previously (29). Yeast transformation was performed using the lithium acetate method (30).
Plasmid Constructions--
pJSC2
(pGAL1::GST-SCD5) and pJSC12
(pGAL1::GST-scd5- 338) were generated
in two steps. First a 0.68-kb BamHI-SalI fragment (containing the SCD5 start codon at the BamHI
site) was moved from pKRH20 (pGBD-scd5- 645 (27)) into the
yeast glutathione S-transferase (GST) expression vector,
pTB338 (CEN, LEU2, and GAL1::GST from Michael
Hall), to generate an in-frame fusion between GST and SCD5
codons 1-227 under control of the GAL1 promoter (pJSC1). Then the remainder of SCD5 or scd5- 338 was
reconstituted by inserting a 5.4-kb XbaI-SphI
fragment (contains codons 188 through the end of the open reading
frame) into pJSC1 to generate pJSC2 and pJSC12, respectively. A 516-bp
BamHI-PstI PCR fragment (codons 828-1000 from
BMS1) was amplified with primers
5'-CCAGGATCCGAAGACATCGTTGG-3' and
5'-GAACTGCAGTATCACTCATTAGGATTTTATCC-3'. This was subcloned in-frame
with GST coding sequences in pTB338 to generate pDG101 (pGAL::GST-bms1-(828-1000)). PP1-binding
site mutant plasmids, pJSC8 (scd5-PP1 1), pJSC9
(scd5-PP1 2), and pJSC10 (scd5-PP1 1 2) were constructed by megaprimer mutagenesis (31). Primer
5'-ACTGGTGATCAAAAGGCCGCTGCTGACTCATTTGCTTCA-3' was used for changing
codons for KVDF (residues 240-243) to KAAA ( 1). Codons for KKVRF
(residues 272-276) were changed to AKAAA ( 2) using the primer
5'-GTTATATGCTCTGAAGCGGCCGCCTTCGCACTCTTAAAATTC-3'. PCR fragments
containing mutations were then gap-repaired into pCC545 (from Clarence
Chan), which contains SCD5 in pRS315 (CEN, LEU2) (32). Regions amplified were verified by DNA
sequencing. For two-hybrid analysis, pJSC18
(pGBD-scd5- 338-PP1 1), pJSC19 (pGBD-scd5- 338-PP1 2), and pJSC20
(pGBD-scd5- 338-PP1 1 2) were generated by gap-repair
of the XbaI-SexAI cut pNT1
(pGBD-scd5- 338 (27)) with fragments containing the mutant
sequences from pJSC8, pJSC9, and pJSC10, respectively. pJSC6
(pGBD-scd5- 523) and pKRH20 (pGBD-scd5- 645
(27)) contain mutant alleles of Scd5p with stop codons at codons 350 and 228, respectively. All two-hybrid Gal4 DNA-binding domain (GBD)
clones were made in pGBDU (2-µ, URA3) (33). pGAD is
a 2-µ, LEU2 two-hybrid activation domain plasmid (33). pGAD-GLC7 (9) and pGAD-GAC1 (6) express
Glc7p and Gac1p fused to the Gal4 activation domain from a
LEU2 prey plasmid, respectively. YCp-HA-GLC7 was
described previously (34). YEp24 (35), YEpSCD5 (36), and
YEpGLC7 (from Michael Stark) are 2-µ, URA3 multicopy plasmids.
Affinity Isolation of GST-Scd5p and GST-scd5p- 338 Fusion
Proteins--
pJSC2 (GST-SCD5), pJSC12
(GST-scd5- 338), or pDG101
(GST-bms1-(828-1000)) were transformed
into a protease-deficient strain, BJ2168, containing
YCp-HA-GLC7. Transformants were grown in 5 ml of synthetic
complete (SC) medium lacking uracil and leucine and containing 1.95%
galactose and 0.05% glucose at 30 °C overnight and then diluted and
grown in 50 ml of the same medium until cultures reached ~1.0 × 107 cells/ml. Approximately 50 × 107
cells were harvested, resuspended in 1.2 ml of cold lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet
P-40, 1 mM phenylmethylsulfonyl fluoride plus a protease
inhibitor mixture (37)), and lysed by glass beads in a Braun
homogenizer for 3 min. Cell extracts were transferred to an ice-cold
centrifuge tube and spun down at 20,800 × g for 30 min
at 4 °C. The supernatant was saved, and protein concentration was
determined using the Bio-Rad protein determination kit. Extracts (420 µg) diluted to 5 ml with lysis buffer were incubated with 100 µl of
a 75% (v/v) slurry of glutathione-Sepharose 4B beads (Amersham
Biosciences) for 3 h at 4 °C with gentle mixing. The Sepharose
beads were pelleted and washed four times with 1 ml of lysis buffer and
one time with 1 ml of lysis buffer without detergent. The final bead
pellets were resuspended in 100 µl of 2× SDS-PAGE sample buffer and
boiled for 5 min. Samples (30 µg) of crude extract were also diluted
to 100 µl with sample buffer and boiled for 5 min. Crude extract and
equal volumes of GST affinity-purified samples were separated by
SDS-PAGE and transferred to nitrocellulose for immunoblotting. Western
blots were probed with affinity-purified rabbit antibodies to GST
(1:1500, Santa Cruz Biotechnology) or anti-HA rat monoclonal antibodies
3F10 (1:750, Roche Molecular Biochemicals). These were detected by
horseradish peroxidase-conjugated goat anti-rabbit IgG (1:10,000,
Sigma) or rabbit anti-rat IgG (1:10,000, Sigma), respectively, and
enhanced chemiluminescence (Amersham Biosciences).
Immunoblotting of Scd5p--
Yeast cells were grown to log phase
in 5 ml of synthetic selective medium at 25 °C. Approximately 2 × 107 cells were harvested, washed with distilled
H2O, and resuspended in 0.1 ml of 2× SDS-PAGE sample
buffer containing 1 mM phenylmethylsulfonyl fluoride plus a
protease inhibitor mixture (37). After lysis with glass beads, extracts
(22 µl) were separated by SDS-PAGE and transferred to nitrocellulose
for immunoblotting. Equal loading of protein was confirmed by Amido
Black staining of transfers. Blots were probed with rabbit anti-Scd5p
antibodies (1:6,000, from Clarence Chan) and developed as described
above for GST-pulldowns.
Two-hybrid Analysis--
Bait plasmids (URA3, pGBD
fusions) were transformed into YPJ96-4A, and prey plasmids
(LEU2, pGAD fusions) were transformed into SL3004. YPJ96-4A
and SL3004 containing these plasmids were mated pairwise on a YEPD
plate for 2 days, and the diploids containing both plasmids were
selected on C-LEU-URA. Cells were grown in liquid C-LEU-URA medium to a
concentration of 0.5 × 107 cells/ml, and equal
numbers of cells were spotted on C-LEU-URA and C-LEU-URA-ADE to monitor
expression of the GAL2-ADE2 reporter gene. -Galactosidase
assays were performed as described previously (38, 39). Miller units of
-galactosidase activity were calculated from three independent
cultures (40).
Endocytosis Assays--
The lucifer yellow (LY) uptake assay was
performed essentially as described previously (41). Cells were grown at
25 °C in YEPD to early log phase, and cultures were kept at 25 °C
or pre-shifted to 37 °C for 15 min before addition of LY (Sigma).
After incubation for 1 h at 25 or 37 °C, cells were washed and
observed immediately with a Zeiss Axioplan-2 fluorescence microscope
equipped with DIC optics as described previously (27). The
35S-labeled -factor internalization assay was performed
as described previously (42).
Actin Staining--
Yeast cells were grown in YEPD to early log
phase, fixed with formaldehyde, and stained with Alexa-568-phalloidin
(Molecular Probes) as described previously (43). Immunofluorescence was performed as described previously (44). Cells were fixed using a
methanol/acetone dehydration method and stained with anti-actin guinea
pig antibodies (1:2,000 (45)), followed by incubation with
Alexa-594-conjugated goat anti-guinea pig IgG (1:800; Molecular Probes). Microscopy was performed using a LSM 410 confocal microscope (Fig. 6, phalloidin staining) or a Zeiss Axioplan-2 microscope (Fig. 6,
anti-actin staining; Fig. 7) as described previously (27).
 |
RESULTS |
Scd5p Interacts with Glc7p in Vivo--
Previous two-hybrid
screens using Glc7p as a bait identified Scd5p as an interacting
protein (10, 25), suggesting that Scd5p might be a regulatory subunit
of yeast PP1. To test whether Scd5p interacts with Glc7p in
vivo, we expressed GST fusions of Scd5p and Scd5p- 338 (a
C-terminal truncation of 338 amino acids) in wild type yeast also
expressing an HA-tagged version of Glc7p. Cells were grown on galactose
to induce expression of the GST fusion proteins, which were then
affinity-purified from protein extracts using glutathione-Sepharose
(Fig. 1). HA-tagged Glc7p corresponding
to a band of 37 kDa co-purified with both GST-Scd5p and
GST-Scd5p- 338 (Fig. 1B, lanes 2 and
3) but not with a nonrelevant control GST fusion (Fig.
1B, lane 1). These data confirm the
previous two-hybrid interaction of Glc7p with Scd5p, as well as a
recent large scale proteomic complex analysis showing Scd5p
co-purification with yeast PP1 (26). In addition, our results show that
the Glc7p interaction in vivo is dependent upon the first
534 amino acids of Scd5p.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 1.
Scd5p associates with Glc7p in
vivo. pJSC2 (GST-SCD5), pJSC12
(GST-scd5- 338), and a negative control, pDG101
(GST-bms1-(828-1000)) were transformed into a
protease-deficient strain, BJ2168, expressing HA-Glc7p. GST fusion
proteins were induced for expression and affinity-purified from protein
extracts using glutathione-Sepharose 4B beads. Samples were subjected
to SDS-PAGE and immunoblot analysis, probing with anti-GST antibodies
to detect GST fusions (A) or anti-HA monoclonal antibodies
to detect HA-Glc7p (B). Blots of equal amounts of whole cell
extracts were probed with anti-HA antibodies to confirm equal
expression of HA-Glc7p (C). The ~70-kDa bands detected by
anti-GST antibodies (A, lanes 2 and 3) are likely
degradation products of GST-Scd5 fusion proteins.
|
|
A Putative PP1-binding Motif Is Required for Interaction of Scd5p
with Glc7p--
To define further the region of Scd5p mediating
interaction with PP1, a series of truncation constructs comprising
C-terminal deletions of Scd5p were fused to the DNA-binding domain of
Gal4p (GBD) (see Fig. 2A) and
tested by two-hybrid analysis for interaction with Glc7p fused to the
Gal4p activation domain (GAD). Scd5p- 338 (residues 1-534) and
Scd5p- 523 (residues 1-349) strongly interacted with Glc7p, whereas
Scd5p- 645 (residues 1-227) could no longer bind yeast PP1 (Fig.
2B). A control prey, GAD-Gac1p, showed no detectable
interaction with any of Scd5p truncation constructs. These two-hybrid
results map the PP1-binding site to a region between amino acids 228 and 349 of Scd5p.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
Two putative PP1-binding motifs in Scd5p are
located within the region that binds Glc7p. A,
schematic diagram of Scd5p. Scd5p (872 amino acids) contains two
putative PP1-binding motifs (KVDF and KKVRF), three repeats of 20 amino
acids (gray boxes), and nine repeats of 12 amino acids
(black boxes). Arrowheads indicate the positions
of stop codons that generate Scd5p-C-terminal truncations of 645, 523, and 338 amino acids used in two-hybrid analysis shown in B. B, two-hybrid interaction of Scd5 truncation proteins with
Glc7p. Yeast strain YPJ96-4A (MATa) was transformed
with Gal4-binding domain (GBD) bait plasmids pKRH20
(GBD-scd5- 645), pJSC6 (GBD-scd5- 523), or
pNT1 (GBD-scd5- 338), and SL3004 (MAT ) was
transformed with Gal4 activation domain (GAD) prey plasmids
pGAD-GLC7 or pGAD-GAC1. Baits and preys were
combined by the mating method described under "Experimental
Procedures," and then diploids were spot plated on medium lacking
leucine and uracil (C-LEU-URA) to monitor growth or medium lacking
leucine, uracil, and adenine (C-LEU-URA-ADE) to assay for two-hybrid
activation of the GAL2:ADE2 reporter. Plates were grown for
3 days at 30 °C. Note that full-length Scd5p fused to GBD
self-activated, so it was not included in B.
|
|
A number of mammalian and yeast PP1-binding proteins contain a
consensus PP1-binding motif ((R/K)(V/I)XF or
(R/K)X(V/I)XF) through which they interact with
the PP1 catalytic subunit, although the latter motif is most common in
yeast (18, 19). Interestingly, Scd5p contains two potential PP1-binding
sequences: KVDF (amino acids 240-243) and KKVRF (amino acids 272-276)
that are located in the Glc7p-binding region defined by the two-hybrid
Scd5p truncation analysis.
To determine whether the putative PP1-binding motifs in Scd5p are
important for binding Glc7p, we mutated these sites singly or in
combination, changing KVDF (240-243) to KAAA ( 1) and KKVRF (272-276) to AKAAA ( 2). These mutations were introduced into the
pGBD-scd5- 338 plasmid to test for two-hybrid interactions with GAD-Glc7p (Fig. 3). We found that
Scd5p- 338-PP1 1 containing KVDF(240-243)KAAA showed wild type
interaction, whereas interaction of Glc7p with Scd5p- 338-PP1 2
containing KKVRF(272-276)AKAAA was reduced ~10-fold. Mutation of
both sites ( 1 2) completely disrupted Glc7p binding (Fig. 3,
A and B). These results indicated that the second
PP1-binding motif is most important for association of Scd5p with
Glc7p, but the first site might contribute to the interaction.

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of Scd5p PP1-binding motif mutations
on the interaction of Scd5p with Glc7p. A, YPJ96-4A
(MATa) was transformed with pGBDU (empty vector), pNT1
(pGBD-scd5- 338), pJSC18
(pGBD-scd5- 338-PP1 1), pJSC19
(pGBD-scd5- 338-PP1 2), or pJSC20
(pGBD-scd5- 338-PP1 1 2). These were mated to SL3004
(MAT ) transformed with pGAD (empty vector) or
pGAD-GLC7, and diploids were spotted and grown on selective
medium as described in Fig. 2B. B, two-hybrid
interactions shown in A were quantified by measuring
-galactosidase activity. Results are the average of three
independent transformants expressed in Miller units ± S.D.
WT, wild type.
|
|
The Second PP1-binding Motif (KKVRF) Is Crucial for Scd5p
Function--
To determine whether these potential PP1-binding motifs
are important for Scd5p function, mutations in each or both of the sites were introduced into the full-length SCD5 expressed
from its own promoter on a CEN LEU2 plasmid and tested for
complementation of the scd5 null allele. YCp plasmids
carrying scd5-PP1-binding site mutations were transformed
into SL4121, which carries a
scd5- ::TRP1 disruption but is viable
because of the presence of SCD5 on a URA3 2-µ
plasmid. Following plasmid shuffling on 5-FOA to force loss of the
URA3 plasmid, the YCp, LEU2 plasmids became the
sole source of Scd5 protein. Whereas cells expressing only
scd5-PP1 1 grew normally at 25 and 37 °C,
scd5-PP1 2 cells were temperature-sensitive for growth at
37 °C (Fig. 4A). Moreover,
the double mutant ( 1 2) failed to complement a scd5
null mutation at any temperature (Fig. 4A).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 4.
Test for rescue of
scd5- ::TRP1 inviability
by Scd5p containing PP1-binding motif mutations.
A, SL4121 (scd5- ::TRP1 + YEpSCD5 (URA3 plasmid)) was transformed with the
CEN LEU2 plasmids pCC545 (SCD5), pJSC8
(scd5-PP1 1), pJSC9 (scd5-PP1 2), or pJSC10
(scd5-PP1 1 2) and grown on synthetic complete medium
lacking leucine and uracil (C-LEU-URA) or medium lacking leucine and
containing 5-fluoroorotic acid (C-LEU+5-FOA) to select against the
YEpSCD5 plasmid with the URA3 marker. Plates were
grown for 3 days at 25 or 37 °C as indicated. B, Western
blot analysis of PP1-binding motif mutants. Equal amounts of proteins
from cell extracts of wild type (SL4415), scd5-PP1 1
(SL4416), and scd5-PP1 2 (SL4417) were analyzed by
immunoblotting with anti-Scd5p antibodies.
|
|
Immunoblot analysis showed that Scd5p-PP1 1 was expressed at levels
identical to the wild type protein, and Scd5p-PP1 2 was even slightly
more abundant that normal Scd5p (Fig. 4B). We were unable to
examine expression of the double mutant protein directly, since the
strain is inviable. However, preliminary studies from expression of the
double mutant protein in the presence of a functional copy of
SCD5 suggest that the double mutation causes protein
instability.2 This would
explain the lack of interaction in the two-hybrid analysis and the lack
of complementation of the null mutation at all temperatures. Thus, we
conclude that the second PP1-binding site is most important for
interaction of Glc7p with Scd5p and for the function of Scd5p.
The scd5-PP1 2 Mutation Causes Defects in Endocytosis and Actin
Organization--
Recently our laboratory has shown that Scd5p plays a
critical role in endocytosis and actin cytoskeleton organization (27). Scd5p also co-localizes with cortical actin patches and physically or
genetically interacts with a number of cortical actin patch components,
many of which are also important for actin organization and endocytosis
(27). Therefore, we examined whether the Scd5p-PP1-binding site
mutations affect these processes.
We first assayed endocytosis of lucifer yellow (LY), a fluid phase
marker that accumulates in the vacuole upon internalization. Both
scd5-PP1 1 and scd5-PP1 2 cells internalized
the dye efficiently at 25 °C (Fig.
5A). When cells were shifted
to 37 °C for 15 min, scd5-PP1 1 cells still showed
normal uptake, but endocytosis of LY by scd5-PP1 2
cells was completely blocked (Fig. 5A). Receptor-mediated endocytosis of radiolabeled -factor by its receptor, Ste2p, was normal in cells with scd5-PP1 1 at 24 and 37 °C. In
contrast, -factor uptake was impaired in scd5-PP1 2
cells at 24 and 37 °C, although the defect at 24 °C was less
severe (Fig. 5B). Thus, the scd5-PP1 2 mutation
causes defects in both fluid phase and receptor-mediated
endocytosis.

View larger version (69K):
[in this window]
[in a new window]
|
Fig. 5.
Fluid phase- and receptor-mediated
endocytosis are defective in scd5-PP1 2 cells.
A, LY accumulation. Wild type (WT) (SL4415),
scd5-PP1 1 (SL4416), and scd5-PP1 2 (SL4417)
cells were preincubated at 25 or 37 °C for 15 min prior to addition
of LY. Cells were further incubated at 25 or 37 °C for 1 h and
immediately visualized using DIC (right panels) and
fluorescence (left panels) microscopy. B,
radiolabeled -factor internalization. Wild type (SL4436;
circles), scd5-PP1 1 (SL4437;
squares), and scd5-PP1 2 (SL4438;
triangles) cells were preincubated at 24 or 37 °C for 15 min. 35S-Labeled -factor was added, and samples were
collected at indicated time points for determination of percent of
cell-associated -factor internalized. The results shown are the
averages of three independent experiments.
|
|
We next examined the effect of the Scd5p-PP1-binding motif mutations on
the actin cytoskeleton by staining cells with Alexa-564 phalloidin to
visualize assembled filamentous (F) actin. In yeast, actin cables,
which are bundles of actin filaments, extend from the mother cell into
the bud for polarized delivery of organelles and other materials into
the growing daughter cell. Cables reorient toward the mother/daughter
cell neck during cytokinesis. Cortical patches appear at the site of
bud emergence and then localize primarily to the growing bud. Late in
the cell cycle they concentrate at the bud neck for septum formation
and cytokinesis.
Cells expressing scd5-PP1 1 exhibited normal actin
structures throughout the cell cycle at 25 and 37 °C, similar to
those observed in wild type cells (Fig.
6). The scd5-PP1 2 strain
grown at 25 °C also displayed a relatively normal polarized
distribution of cortical actin patches and cables. In contrast, actin
structures were aberrant in scd5-PP1 2 cells shifted to
37 °C (Fig. 6). In small- and medium-budded cells many actin patches
were polarized to the daughter cells, but significant depolarization to
mother cells was also observed. In addition, actin cables were often misoriented and much thinner or hardly visible, as compared with those
seen in the wild type and scd5-PP1 1 cells. In
large-budded cells increased numbers of actin patches were seen
distributed throughout cells with scd5-PP1 2. These
patches were often much larger than normal, and an actin ring at the
bud neck was rarely observed. In addition, actin cables were barely
visible.

View larger version (87K):
[in this window]
[in a new window]
|
Fig. 6.
Actin organization is defective in
scd5-PP1 2 cells. Wild type (WT)
(SL4418), scd5-PP1 1 (SL4419), and scd5-PP1 2
(SL4420) cells were grown to log phase in YEPD at 25 °C and
preincubated at 25 or 37 °C for 3.5 h before fixation.
Upper panels, filamentous actin was stained with Alexa-568
phalloidin and visualized using a LSM 410 confocal microscope.
Lower panels, both F- and G-actins in
scd5-PP1 2 (SL4420) cells were visualized by indirect
immunofluorescence, staining with anti-actin antibodies.
|
|
Cells were also stained with anti-actin antibodies, which allows
visualization of both F- and G-actin. The scd5-PP1 2 cells often (up to 11% of cells at 37 °C) contained G-actin bars, which are thought to be aggregates of monomeric or disassembled actin (Fig.
6), whereas none of the wild type and scd5-PP1 1 cells
displayed the actin bar phenotype (data not shown). The overall size of scd5-PP1 2 cells throughout the cell cycle was also larger
than normal at both 25 and 37 °C (see Figs. 6 and
7), consistent with effects on the actin
cytoskeleton and polarized growth.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 7.
Overexpression of GLC7
suppresses the scd5-PP1 2 growth and actin
phenotypes. A, suppression of scd5-PP1 2
temperature-sensitive growth. SL4417
(scd5- ::TRP1 + pJSC9
(scd5-PP1 2)) was transformed with YEp24 or
YEpGLC7 and streaked for growth on YEPD for 3 days at 25 or
37 °C. B, partial rescue of the scd5-PP1 2
actin organization phenotype. SL4420 transformed with YEp24 or
YEpGLC7 or a wild type strain (SL4418) transformed with
YEpGLC7 were grown to log phase in selective medium at
25 °C and shifted to 37 °C for 3.5h before fixation. Filamentous
actin was stained with Alexa-568 phalloidin and visualized by
fluorescence microscopy. Bar graph shows the percent of
cells with normal actin organization in SL4420 cells
(scd5-PP1 2) containing YEp24 or YEpGLC7.
|
|
Overexpression of GLC7 Suppresses scd5-PP1 2--
Often when
phenotypes in yeast are caused by a mutation that affects the
productive interaction of two proteins, the defects can be suppressed
by overexpression of the interacting partner. Thus we tested whether
overexpression of PP1 can suppress the phenotypes caused by the
scd5-PP1 2 mutation. We found scd5-PP1 2 cells carrying a vector control (YEp24) were inviable at the
restrictive temperature of 37 °C, whereas growth was rescued when
cells were transformed with GLC7 expressed from a multicopy
plasmid (Fig. 7A). Although LY uptake was still defective in
the scd5-PP1 2 mutant overexpressing GLC7 (not
shown), the actin organization phenotype was also partially suppressed
by YEpGLC7 (Fig. 7B). Nearly 50% of mutant cells
overexpressing GLC7 displayed highly polarized actin patches
and normally oriented actin cables, similar to wild type cells with
YEpGLC7 (Fig. 7B). In addition, significant numbers of large-budded cells had actin at the site of cytokinesis in
the scd5-PP1 2 strain overexpressing GLC7.
These overexpression studies provide further evidence that Scd5p
interaction with PP1 is important for Scd5p function.
 |
DISCUSSION |
Scd5p Interacts with the Yeast PP1 Homologue, Glc7p, through Its
PP1-binding Motif--
Mutational analysis of a number of PP1
regulatory proteins has shown that alteration of the highly conserved
V/I and/or F residues in their PP1-binding motif disrupts or severely
weakens interaction with PP1 and prevents specific functional targeting of the phosphatase (20-24). In this paper we provide evidence that Scd5p interacts with the GLC7-encoded PP1 in vivo
and that, like other PP1 regulatory proteins, a
(V/I)XF-binding motif in Scd5p is important for PP1
association and the biological function of Scd5p.
The Glc7p-interacting region on Scd5p was mapped to a region containing
two potential PP1-binding motifs, KVDF (240-243) and KKVRF (272-276).
Another potential PP1-binding motif is found at residues 29-33 (PPVSF)
(19), but an N-terminal fragment of Scd5p (amino acids 1-227) could
not associate with Glc7p, indicating that this is not a Glc7p-binding
site. Mutational analysis further revealed that the KKVRF signal is
crucial for interaction of Scd5p with Glc7p, whereas the KVDF motif is
not likely to bind to the PP1 hydrophobic channel in the C terminus of
PP1. Although KVDF contains the highly conserved V/I and F residues, it
contains an acidic residue within the core sequence. Peptide panning
experiments to identify PP1-binding sequences found that the most
frequent residues in the second position of the (V/I)XF
motif were His or Arg (19). In addition, previous work has shown that
phosphorylation of serine at this site prevents binding of
GM to mammalian PPlc (46). This is also predicted by the
crystal structure (18), suggesting that Asp and possibly Glu are not
favorable either. However, a KVEF motif found in mammalian aurora
kinase appears to be important for PP1 binding, suggesting glutamic
acid would be compatible in some contexts (47). Nevertheless our data
suggest that the Asp residue in the KVDF sequence of Scd5p prevents
interaction with residues comprising the hydrophobic pocket of Glc7p,
or alternatively, the KVDF sequence may be inaccessible on the protein
surface of Scd5p for binding to the Glc7p hydrophobic channel.
Whereas alteration of the KKVRF motif in Scd5p severely impaired
interaction with Glc7p, Scd5p appears to have additional contacts on
the Glc7p protein surface, since changing KKVRF to AKAAA did not
completely disrupt binding to Glc7p or Scd5p function at the permissive
temperature and resulted in a temperature-sensitive growth phenotype.
However, the mutation did cause some phenotypic consequences at
24 °C, as the reduced -factor uptake and the actin bar phenotype
were already observed at this temperature, even though the protein was
completely stable. We note that some PP1-binding proteins, such as
M110 (48, 49), AKAP220 (50), and PP1 inhibitors (51-53),
bind PP1 through (V/I)XF motifs but also make additional
contacts on the protein surface of PP1, which increase stability of the
association or regulate activity and specificity. In addition, in
vivo other proteins might form a complex with Scd5p and PP1 to
stabilize their interaction. Although we found that Scd5p mutated at
both the KVDF and KKVRF motifs was not able to rescue the
scd5 mutation, the lack of physical interaction with
Glc7p by two-hybrid analysis or functional complementation by the
double mutant protein most likely results from instability of the
protein.2
Role of Scd5p-PP1 Interaction in Endocytosis and Actin Cytoskeleton
Organization--
In addition to causing temperature-sensitive growth,
scd5-PP1 2 dramatically blocked both
receptor-mediated and fluid phase endocytosis and had a significant
effect on actin organization. Therefore, the critical role of Scd5p in
endocytosis and actin organization most likely requires its interaction
with and targeting of Glc7p. Supporting this, we found that
overexpression of Glc7p could partially rescue Scd5p phenotypes
resulting from mutation of the KKVRF PP1-binding motif. In addition,
previous studies have shown that some glc7 mutations cause a
cortical actin defect (54). A role for PP1 in regulating actin
organization has been demonstrated in animal cells as well. For
example, neurabin I (Nrb I) binds F-actin and recruits PP1 to control
cell morphology (24, 55). When the PP1-binding motif in Nrb I was
altered, the mutant protein failed to bind PP1 and to induce filopodia formation (24).
PP1 regulatory proteins target PP1 to distinct subcellular locations or
promote association with specific substrates to reverse or counter the
consequences of regulatory phosphorylation by kinases (1-3). One
example in yeast is the regulation of a glycogen synthase by a
Gac1p/PP1 holoenzyme in glycogen synthesis. Gac1p targets PP1 to a
glycogen synthase (Gsy2p) and reverses phosphorylation and inactivation
of Gsy2p by cyclin-dependent kinase Pho85p (7, 56-59). By
analogy, Scd5p may direct PP1 to dephosphorylate actin patch-associated
components for regulation of actin organization and endocytosis. Our
recent work (27) has shown that Scd5p partially co-localizes with actin
patches and physically associates with actin patch proteins, such as
Sla2p/End4p and Rvs167p (60, 61), both of which are also important for
endocytosis (41, 63). In addition, the cortical localization of Sla2p
is dependent upon Scd5p (27).
Recent studies (64, 65) indicate that yeast actin-regulating kinases
(ARKs), including Prk1p and Ark1p, play a role in actin organization
and endocytosis. Prk1p and Ark1p localize to cortical actin patches
(64, 65) and likely promote actin patch disassembly by phosphorylating
target proteins, since many cortical actin-associated proteins collapse
into large F-actin aggregates in ark1 prk1 double mutant
cells (64). Prk1p negatively regulates the interaction of actin
patch/endocytic factors Pan1p, End3p, and Sla1p by phosphorylating a
repeated motif ((L/I)XXQXTG) found in Pan1p and
Sla1p (65, 66). Prk1p also regulates Pan1p interacting proteins,
Ent1/2p, which contain Pan1p-consensus sequences (67). As a PP1
targeting subunit, Scd5p/Glc7p could counter kinases, such as ARKs,
that act on cortical actin components.
Interestingly, Scd5p also contains sites that could be targets of
regulatory phosphorylation, including a central repeat that has motifs
related to those found in other Prk1p substrates. Thus, Scd5p, itself,
could be regulated by ARKs or other kinases. This raises the
possibility that Scd5p is also a PP1 substrate, and the binding of PP1
reverses regulatory phosphorylation on Scd5p. This would be similar to
the role of Glc7p binding to Reg1p in association with Snf1 kinase for
glucose repression. Glc7p dephosphorylates both Snf1p and Reg1p during
a regulatory cascade that turns off Snf1p in high glucose conditions
(62). Further studies are underway to determine whether PP1 regulates
Scd5p directly and what are the targets of PP1 in association with
Scd5p for regulation of actin organization and endocytosis in yeast.
 |
ACKNOWLEDGEMENTS |
We thank Marian Carlson, Michael
Stark, Michael Hall, Elizabeth Jones, David Botstein, and Clarence
Chan who provided plasmids, strains, and antibodies. We also thank
Kelly Tatchell for materials and helpful discussions.
 |
FOOTNOTES |
*
This work was supported in part by National Institutes of
Health Grant R01 GM55796 (to S. K. L.) and the Deutsche
Forshungsgemeinschaft Project SFB 352 (to M. G.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by an individual National Research Service Award Minority
Predoctoral Fellowship F31 GM20082.
To whom correspondence should be addressed: Dept. of
Molecular Biology and Microbiology, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106-4960. Tel.: 216-368-6279; Fax:
216-368-3055; E-mail: skl@po.cwru.edu.
Published, JBC Papers in Press, September 27, 2002, DOI 10.1074/jbc.M208471200
2
J. Chang, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
PP1, type I Ser/Thr
protein phosphatase;
YEPD, yeast extract peptone dextrose;
5-FOA, 5-fluoroorotic acid;
GST, glutathione S-transferase;
HA, hemagglutinin;
GBD, Gal4p-binding domain;
GAD, Gal4p activation domain;
URA, uracil;
ADE, adenine;
LEU, leucine;
LY, Lucifer Yellow;
ARK, actin-regulating kinase.
 |
REFERENCES |
| 1.
|
Shenolikar, S.
(1994)
Annu. Rev. Cell Biol.
10,
55-86[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Stark, M. J. R.
(1996)
Yeast
12,
1647-1675[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Hubbard, M. J.,
and Cohen, P.
(1993)
Trends Biochem. Sci.
18,
172-177[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Feng, Z. H.,
Wilson, S. E.,
Peng, Z. Y.,
Schlender, K. K.,
Reimann, E. M.,
and Trumbly, R. J.
(1991)
J. Biol. Chem.
266,
23796-23801[Abstract/Free Full Text]
|
| 5.
|
Ohkura, H.,
Kinoshita, N.,
Miyatani, S.,
Toda, T.,
and Yanagida, M.
(1989)
Cell
57,
997-1007[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Stuart, J. S.,
Frederick, D. L.,
Varner, C. M.,
and Tatchell, K.
(1994)
Mol. Cell. Biol.
14,
896-905[Abstract/Free Full Text]
|
| 7.
|
Francois, J. M.,
Thompson-Jaeger, S.,
Skroch, J.,
Zellenka, U.,
Spevak, W.,
and Tatchell, K.
(1992)
EMBO J.
11,
87-96[Medline]
[Order article via Infotrieve]
|
| 8.
|
Huang, D.,
Chun, K. T.,
Goebl, M. G.,
and Roach, P. J.
(1996)
Genetics
143,
119-127[Abstract]
|
| 9.
|
Tu, J.,
and Carlson, M.
(1995)
EMBO J.
14,
5939-5946[Medline]
[Order article via Infotrieve]
|
| 10.
|
Tu, J.,
Song, W.,
and Carlson, M.
(1996)
Mol. Cell. Biol.
16,
4199-4206[Abstract]
|
| 11.
|
Rockmill, B.,
and Roeder, G. S.
(1990)
Genetics
126,
563-574[Abstract]
|
| 12.
|
Tachikawa, H.,
Bloecher, A.,
Tatchell, K.,
and Neiman, A. M.
(2001)
J. Cell Biol.
155,
797-808[Abstract/Free Full Text]
|
| 13.
|
Stone, E. M.,
Yamano, H.,
Kinoshita, N.,
and Yanagida, M.
(1993)
Curr. Biol.
3,
13-26[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
MacKelvie, S. H.,
Andrews, P. D.,
and Stark, M. J.
(1995)
Mol. Cell. Biol.
15,
3777-3785[Abstract]
|
| 15.
|
Hisamoto, N.,
Frederick, D. L.,
Sugimoto, K.,
Tatchell, K.,
and Matsumoto, K.
(1995)
Mol. Cell. Biol.
15,
3767-3776[Abstract]
|
| 16.
|
Cannon, J. F.,
Pringle, J. R.,
Fiechter, A.,
and Khalil, M.
(1994)
Genetics
136,
485-503[Abstract]
|
| 17.
|
Tung, H. Y.,
Wang, W.,
and Chan, C. S.
(1995)
Mol. Cell. Biol.
15,
6064-6074[Abstract]
|
| 18.
|
Egloff, M. P.,
Johnson, D. F.,
Moorhead, G.,
Cohen, P. T.,
Cohen, P.,
and Barford, D.
(1997)
EMBO J.
16,
1876-1887[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Zhao, S.,
and Lee, E. Y.
(1997)
J. Biol. Chem.
272,
28368-28372[Abstract/Free Full Text]
|
| 20.
|
Wu, X.,
Hart, H.,
Cheng, C.,
Roach, P. J.,
and Tatchell, K.
(2001)
Mol. Genet. Genomics
265,
622-635[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Dombek, K. M.,
Voronkova, V.,
Raney, A.,
and Young, E. T.
(1999)
Mol. Cell. Biol.
19,
6029-6040[Abstract/Free Full Text]
|
| 22.
|
Fong, N. M.,
Jensen, T. C.,
Shah, A. S.,
Parekh, N. N.,
Saltiel, A. R.,
and Brady, M. J.
(2000)
J. Biol. Chem.
275,
35034-35039[Abstract/Free Full Text]
|
| 23.
|
Trinkle-Mulcahy, L.,
Ajuh, P.,
Prescott, A.,
Claverie-Martin, F.,
Cohen, S.,
Lamond, A. I.,
and Cohen, P.
(1999)
J. Cell Sci.
112,
157-168[Abstract]
|
| 24.
|
Oliver, C. J.,
Terry-Lorenzo, R. T.,
Elliott, E.,
Bloomer, W. A., Li, S.,
Brautigan, D. L.,
Colbran, R. J.,
and Shenolikar, S.
(2002)
Mol. Cell. Biol.
22,
4690-4701[Abstract/Free Full Text]
|
| 25.
|
Uetz, P.,
Giot, L.,
Cagney, G.,
Mansfield, T. A.,
Judson, R. S.,
Knight, J. R.,
Lockshon, D.,
Narayan, V.,
Srinivasan, M.,
Pochart, P.,
Qureshi-Emili, A., Li, Y.,
Godwin, B.,
Conover, D.,
Kalbfleisch, T.,
Vijayadamodar, G.,
Yang, M.,
Johnston, M.,
Fields, S.,
and Rothberg, J. M.
(2000)
Nature
403,
623-627[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Ho, Y.,
Gruhler, A.,
Heilbut, A.,
Bader, G. D.,
Moore, L.,
Adams, S. L.,
Millar, A.,
Taylor, P.,
Bennett, K.,
Boutilier, K.,
Yang, L.,
Wolting, C.,
Donaldson, I.,
Schandorff, S.,
Shewnarane, J., Vo, M.,
Taggart, J.,
Goudreault, M.,
Muskat, B.,
Alfarano, C.,
Dewar, D.,
Lin, Z.,
Michalickova, K.,
Willems, A. R.,
Sassi, H.,
Nielsen, P. A.,
Rasmussen, K. J.,
Andersen, J. R.,
Johansen, L. E.,
Hansen, L. H.,
Jespersen, H.,
Podtelejnikov, A.,
Nielsen, E.,
Crawford, J.,
Poulsen, V.,
Sorensen, B. D.,
Matthiesen, J.,
Hendrickson, R. C.,
Gleeson, F.,
Pawson, T.,
Moran, M. F.,
Durocher, D.,
Mann, M.,
Hogue, C. W.,
Figeys, D.,
and Tyers, M.
(2002)
Nature
415,
180-183[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Henry, K. R.,
D'Hondt, K.,
Chang, J.,
Newpher, T.,
Huang, K.,
Hudson, R. T.,
Riezman, H.,
and Lemmon, S. K.
(2002)
Mol. Biol. Cell
13,
2607-2625[Abstract/Free Full Text]
|
| 28.
|
Nelson, K. K.,
and Lemmon, S. K.
(1993)
Mol. Cell. Biol.
13,
521-532[Abstract/Free Full Text]
|
| 29.
|
Boeke, J. D.,
LaCroute, F.,
and Fink, G. R.
(1984)
Mol. Gen. Genet.
197,
345-346[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Gietz, R. D.,
Schiestl, R. H.,
Willems, A. R.,
and Woods, R. A.
(1995)
Yeast
11,
355-360[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Aiyar, A.
(1993)
BioTechniques
14,
366-367[Medline]
[Order article via Infotrieve]
|
| 32.
|
Sikorski, R. S.,
and Hieter, P.
(1989)
Genetics
122,
19-27[Abstract/Free Full Text]
|
| 33.
|
James, P.,
Halladay, J.,
and Craig, E. A.
(1996)
Genetics
144,
1425-1436[Abstract]
|
| 34.
|
Sutton, A.,
Immanuel, D.,
and Arndt, K. T.
(1991)
Mol. Cell. Biol.
11,
2133-2148[Abstract/Free Full Text]
|
| 35.
|
Botstein, D.,
Falco, S. C.,
Stewart, S. E.,
Brennan, M.,
Scherer, S.,
Stinchcomb, D. T.,
Struhl, K.,
and Davis, R. W.
(1979)
Gene (Amst.)
8,
17-24[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Nelson, K. K.,
Holmer, M.,
and Lemmon, S. K.
(1996)
Mol. Biol. Cell
7,
245-260[Abstract]
|
| 37.
|
Stepp, J. D.,
Pellicena-Palle, A.,
Hamilton, S.,
Kirchhausen, T.,
and Lemmon, S. K.
(1995)
Mol. Biol. Cell
6,
41-58[Abstract]
|
| 38.
|
Kaiser, C.,
Michaelis, S.,
and Mitchell, A.
(1994)
Methods in Yeast Genetics: A Cold Spring Harbor Laboratory Course Manual
, pp. 169-173, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 39.
|
Yocum, R. R.,
Hanley, S.,
West, R.,
and Ptashne, M.
(1984)
Mol. Cell. Biol.
4,
1985-1998[Abstract/Free Full Text]
|
| 40.
|
Miller, J. H.
(1972)
Experiments in Molecular Genetics
, pp. 352-355, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 41.
|
Munn, A. L.,
Stevenson, B. J.,
Geli, M. I.,
and Riezman, H.
(1995)
Mol. Biol. Cell
6,
1721-1742[Abstract]
|
| 42.
|
Dulic, V.,
Egerton, M.,
Elguindi, I.,
Raths, S.,
Singer, B.,
and Riezman, H.
(1991)
Methods Enzymol.
194,
697-710[Medline]
[Order article via Infotrieve]
|
| 43.
|
Adams, A. E.,
and Pringle, J. R.
(1991)
Methods Enzymol.
194,
729-731[Medline]
[Order article via Infotrieve]
|
| 44.
|
Pringle, J. R.,
Adams, A. E. M.,
Drubin, D. G.,
and Haarer, B. K.
(1991)
Methods Enzymol.
194,
565-602[Medline]
[Order article via Infotrieve]
|
| 45.
|
Mulholland, J.,
Preuss, D.,
Moon, A.,
Wong, A.,
Drubin, D.,
and Botstein, D.
(1994)
J. Cell Biol.
125,
381-391[Abstract/Free Full Text]
|
| 46.
|
Hubbard, M. J.,
and Cohen, P.
(1989)
Eur. J. Biochem.
186,
701-709[Medline]
[Order article via Infotrieve]
|
| 47.
|
Katayama, H.,
Zhou, H., Li, Q.,
Tatsuka, M.,
and Sen, S.
(2001)
J. Biol. Chem.
276,
46219-46224[Abstract/Free Full Text]
|
| 48.
|
Johnson, D. F.,
Moorhead, G.,
Caudwell, F. B.,
Cohen, P.,
Chen, Y. H.,
Chen, M. X.,
and Cohen, P. T.
(1996)
Eur. J. Biochem.
239,
317-325[Medline]
[Order article via Infotrieve]
|
| 49.
|
Tanaka, J.,
Ito, M.,
Feng, J.,
Ichikawa, K.,
Hamaguchi, T.,
Nakamura, M.,
Hartshorne, D. J.,
and Nakano, T.
(1998)
Biochemistry
37,
16697-16703[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Schillace, R. V.,
Voltz, J. W.,
Sim, A. T.,
Shenolikar, S.,
and Scott, J. D.
(2001)
J. Biol. Chem.
276,
12128-12134[Abstract/Free Full Text]
|
| 51.
|
Connor, J. H.,
Quan, H. N.,
Ramaswamy, N. T.,
Zhang, L.,
Barik, S.,
Zheng, J.,
Cannon, J. F.,
Lee, E. Y.,
and Shenolikar, S.
(1998)
J. Biol. Chem.
273,
27716-27724[Abstract/Free Full Text]
|
| 52.
|
Park, I. K.,
and DePaoli-Roach, A. A.
(1994)
J. Biol. Chem.
269,
28919-28928[Abstract/Free Full Text]
|
| 53.
|
Huang, H. B.,
Horiuchi, A.,
Watanabe, T.,
Shih, S. R.,
Tsay, H. J., Li, H. C.,
Greengard, P.,
and Nairn, A. C.
(1999)
J. Biol. Chem.
274,
7870-7878[Abstract/Free Full Text]
|
| 54.
|
Andrews, P. D.,
and Stark, M. J.
(2000)
J. Cell Sci.
113,
507-520[Abstract]
|
| 55.
|
McAvoy, T.,
Allen, P. B.,
Obaishi, H.,
Nakanishi, H.,
Takai, Y.,
Greengard, P.,
Nairn, A. C.,
and Hemmings, H. C., Jr.
(1999)
Biochemistry
38,
12943-12949[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Hardy, T. A.,
and Roach, P. J.
(1993)
J. Biol. Chem.
268,
23799-23805[Abstract/Free Full Text]
|
| 57.
|
Huang, D.,
Farkas, I.,
and Roach, P. J.
(1996)
Mol. Cell. Biol.
16,
4357-4365[Abstract]
|
| 58.
|
Huang, D.,
Moffat, J.,
Wilson, W. A.,
Moore, L.,
Cheng, C.,
Roach, P. J.,
and Andrews, B.
(1998)
Mol. Cell. Biol.
18,
3289-3299[Abstract/Free Full Text]
|
| 59.
|
Anderson, C.,
and Tatchell, K.
(2001)
J. Bacteriol.
183,
821-829[Abstract/Free Full Text]
|
| 60.
|
Balguerie, A.,
Sivadon, P.,
Bonneu, M.,
and Aigle, M.
(1999)
J. Cell Sci.
112,
2529-2537[Abstract]
|
| 61.
|
Yang, S.,
Cope, M. J.,
and Drubin, D. G.
(1999)
Mol. Biol. Cell
10,
2265-2283[Abstract/Free Full Text]
|
| 62.
|
Sanz, P.,
Alms, G. R.,
Haystead, T. A.,
and Carlson, M.
(2000)
Mol. Cell. Biol.
20,
1321-1328[Abstract/Free Full Text]
|
| 63.
|
Wesp, A.,
Hicke, L.,
Palecek, J.,
Lombardi, R.,
Aust, T.,
Munn, A. L.,
and Riezman, H.
(1997)
Mol. Biol. Cell
8,
2291-2306[Abstract/Free Full Text]
|
| 64.
|
Cope, M. J.,
Yang, S.,
Shang, C.,
and Drubin, D. G.
(1999)
J. Cell Biol.
144,
1203-1218[Abstract/Free Full Text]
|
| 65.
|
Zeng, G.,
and Cai, M.
(1999)
J. Cell Biol.
144,
71-82[Abstract/Free Full Text]
|
| 66.
|
Zeng, G., Yu, X.,
and Cai, M.
(2001)
Mol. Biol. Cell
12,
3759-3772[Abstract/Free Full Text]
|
| 67.
|
Watson, H. A.,
Cope, M. J.,
Groen, A. C.,
Drubin, D. G.,
and Wendland, B.
(2001)
Mol. Biol. Cell
12,
3668-3679[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Zeng, B. Huang, S. P. Neo, J. Wang, and M. Cai
Scd5p Mediates Phosphoregulation of Actin and Endocytosis by the Type 1 Phosphatase Glc7p in Yeast
Mol. Biol. Cell,
December 1, 2007;
18(12):
4885 - 4898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Alvarez-Tabares, A. Grallert, J.-M. Ortiz, and I. M. Hagan
Schizosaccharomyces pombe protein phosphatase 1 in mitosis, endocytosis and a partnership with Wsh3/Tea4 to control polarised growth
J. Cell Sci.,
October 15, 2007;
120(20):
3589 - 3601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Pedelini, M. Marquina, J. Arino, A. Casamayor, L. Sanz, M. Bollen, P. Sanz, and M. A. Garcia-Gimeno
YPI1 and SDS22 Proteins Regulate the Nuclear Localization and Function of Yeast Type 1 Phosphatase Glc7
J. Biol. Chem.,
February 2, 2007;
282(5):
3282 - 3292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Toshima, J. Y. Toshima, M. C. Duncan, M. J. T.V. Cope, Y. Sun, A. C. Martin, S. Anderson, J. R. Yates III, K. Mizuno, and D. G. Drubin
Negative Regulation of Yeast Eps15-like Arp2/3 Complex Activator, Pan1p, by the Hip1R-related Protein, Sla2p, during Endocytosis
Mol. Biol. Cell,
February 1, 2007;
18(2):
658 - 668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Pinsky, C. V. Kotwaliwale, S. Y. Tatsutani, C. A. Breed, and S. Biggins
Glc7/Protein phosphatase 1 regulatory subunits can oppose the ipl1/aurora protein kinase by redistributing glc7.
Mol. Cell. Biol.,
April 1, 2006;
26(7):
2648 - 2660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Santangelo
Glucose Signaling in Saccharomyces cerevisiae
Microbiol. Mol. Biol. Rev.,
March 1, 2006;
70(1):
253 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Chang, K. Henry, M. I. Geli, and S. K. Lemmon
Cortical Recruitment and Nuclear-Cytoplasmic Shuttling of Scd5p, a Protein Phosphatase-1-targeting Protein Involved in Actin Organization and Endocytosis
Mol. Biol. Cell,
January 1, 2006;
17(1):
251 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Huang, G. Zeng, A. Y.J. Ng, and M. Cai
Identification of Novel Recognition Motifs and Regulatory Targets for the Yeast Actin-regulating Kinase Prk1p
Mol. Biol. Cell,
December 1, 2003;
14(12):
4871 - 4884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Garcia-Gimeno, I. Munoz, J. Arino, and P. Sanz
Molecular Characterization of Ypi1, a Novel Saccharomyces cerevisiae Type 1 Protein Phosphatase Inhibitor
J. Biol. Chem.,
November 28, 2003;
278(48):
47744 - 47752.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|